OOIR: Observatory of International Research

Papers

(The H4-Index of Journal of Cancer Research and Clinical Oncology is 31. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-05-01 to 2025-05-01.)

Article	Citations
Vitiligo-like leukoderma as an indicator of clinical response to immune checkpoint inhibitors in late-stage melanoma patients	162
Sarcopenia indicate poor survival in patients undergoing transarterial chemoembolization (TACE) for hepatic malignancies	134
Therapeutic yield of extensive molecular profiling in cholangiocarcinoma: a retrospective single-center study	100
Heterodimerization of cholecystokinin 1 and cholecystokinin 2 receptors in gallbladder cancer: a new mechanism for carcinogenesis	93
A case of rare metachronous four primary carcinoma	82
Prognostic value of comprehensive typing based on m6A and gene cluster in TNBC	71
A predictive model for patients with local-regionally advanced oropharyngeal squamous cell carcinoma treated after cervical lymph node dissection	69
Pneumatosis intestinalis in cancer patients who received immune checkpoint inhibitors	65
Radiomics-guided prognostic assessment of early-stage hepatocellular carcinoma recurrence post-radical resection	61
Clinical characteristics and long-term outcomes of rhabdomyosarcoma in Korean children, adolescents and young adults: a single-center experience	58
Oral microbiota may predict the presence of esophageal squamous cell carcinoma	57
Early T-cell precursor lymphoblastic leukemia accompanied by prominent blastic plasmacytoid dendritic cell proliferation mimicking blastic plasmacytoid dendritic cell neoplasm: an exceptional case rep	53
Identifying immune infiltration by deep learning to assess the prognosis of patients with hepatocellular carcinoma	50
Performance of endobronchial ultrasound transbronchial needle aspiration as the first nodal staging procedure for the determination of programmed death ligand-1 expression in non-small cell lung cance	50
Combination of multiple nucleic acid aptamers for precision detection of tumors based on optical methods	49
Impact of the COVID-19 pandemic on reported cancer diagnoses in Bavaria, Germany	49
Extracellular urinary microRNAs as non-invasive biomarkers of endometrial and ovarian cancer	48
Precision neuro-oncology: a pilot analysis of personalized treatment in recurrent glioma	46
Exportin XPO7 acts as an oncogenic factor in prostate cancer via upregulation of TCF3	46
Adjuvant radiotherapy in patients with node-positive prostate cancer after radical prostatectomy	43
Hairy cell leukemia: a specific 17-gene expression signature points to new targets for therapy	43
Safety and efficacy of tomosynthesis-guided breast biopsies in the prone position: monocentric study and review of the literature	41
Clinical characteristics of sarcoma patients: a population-based data analysis from a German clinical cancer registry	41
Attitudes toward a COVID-19 vaccine and vaccination status in cancer patients: correspondence	39
Comprehensive bioinformatics analysis of a RBM family-based prognostic signature with experiment validation in hepatocellular carcinoma	39

Can whole-body MRI replace CT in management of metastatic testicular cancer? A prospective, non-inferiority study	39
Expression and clinical prognostic value of CYB561 in breast cancer	38
Oncological outcomes of squamous cell carcinoma of the cervical esophagus treated with definitive (chemo‑)radiotherapy: a systematic review and meta‑analysis. In regard to De Virgilio et al	37
GSTM1 and GSTT1 polymorphisms associated with pain in a chemotherapy-induced peripheral neuropathy cohort	36
Deciphering the implications of mitophagy-related signatures in clinical outcomes and microenvironment heterogeneity of clear cell renal cell carcinoma	33
Comparison of cisplatin and mitomycin C/5-FU as radiosensitisers in the treatment of locally advanced vulvar cancer: results of a retrospective, observational, single-institutional cohort study	31
Introducing a standardized assessment of patients’ interest in and usage of CAM in routine cancer care: chances and risks from patients’ and physicians’ point of view	31
Frequent FGFR1 hotspot alterations in driver-unknown low-grade glioma and mixed neuronal-glial tumors	31